Intramuscular injection, by contrast, deposits peptide 1540mm deep (depending on needle length and injection site), requiring the compound to enter venous return, circulate systemically, and then diffuse back out of dermal capillaries to reach fibroblasts
Frequency: Once per week maximum for at-home treatment
For the FOXO4-DRI treatment group, 50 M FOXO4-DRI (MCE, HY-P4157) was added to the glucose-free DMEM (Gibco, Catalog #11966-025) medium, followed by 3 h of oxygen-glucose deprivation (OGD) treatment
Some patients benefit from monthly sessions, while others may receive infusions more frequently during periods of illness or high physical demand
We appreciate your support and look forward to serving you again